Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Rating) saw a significant decrease in short interest in April. As of April 30th, there was short interest totalling 300 shares, a decrease of 25.0% from the April 15th total of 400 shares. Based on an average daily volume of 1,000 shares, the short-interest ratio is currently 0.3 days.
Separately, Zacks Investment Research upgraded Aspen Pharmacare from a “strong sell” rating to a “hold” rating in a report on Tuesday.
Shares of OTCMKTS:APNHY opened at $9.81 on Wednesday. Aspen Pharmacare has a 1 year low of $9.60 and a 1 year high of $18.79. The business has a fifty day simple moving average of $11.94 and a 200 day simple moving average of $13.15. The company has a current ratio of 1.96, a quick ratio of 1.13 and a debt-to-equity ratio of 0.28.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
- Get a free copy of the StockNews.com research report on Aspen Pharmacare (APNHY)
- Now’s The Time To Buy Disney (NYSE: DIS)
- 3 Small Caps With Big Return Potential
- Target Follows Walmart Lower In A Downward Spiral Of Inflation
- Take-Two Interactive (NASDAQ: TTWO) Moves Back From The Brink
- The Weber, Inc Growth Story Goes Up In Smoke
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.